Publication | Closed Access
Clinical trial of the oral form of a new podophyllotoxin derivative, VP-16-213 (NSC-141540), in patients with advanced neoplastic disease.
30
Citations
0
References
1976
Year
OncologyNew PodophyllotoxinMedicineClinical TrialsPathologyPharmacotherapyOral FormCancer TreatmentPharmacologyMalignant DiseaseNovel TherapyCancer ResearchOral Cancer
No additional data available for this publication yet. Check back later!